Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. Arch Ital Urol Androl. 2025;97(2). doi:10.4081/aiua.2025.13880